E. Coli Testing Market Report by Product (Consumables, Instruments), Test Type (Environmental Test, Clinical Test), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Region 2024-2032
세계의 대장균 검사 시장 규모는 2023년 21억 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 39억 달러에 이를 전망이고, 예측 기간 동안 6.6%의 복합 연간 성장률(CAGR)을 나타낼 것으로 예측했습니다.
대장균(E. Coli) 검사란 식품 유래 병원체의 존재를 검출,감시하는 프로세스를 말합니다. 대장균은 일반적으로 오염된 식품과 물, 원유에서 생산된 치즈, 가열 불충분한 제품, 미살균 우유, 원시 과일 및 채소로부터 검출됩니다. 식중독, 폐렴, 요로 감염(UTI) 등 다양한 질병을 유발할 수 있습니다. 대장균을 검출하는 임상 검사법에는 효소 면역 측정법(EIA)이나 중합효소 연쇄반응법(PCR), 효소 기질법, 막 여과법, 다관 발효법(MTF) 등의 환경 검사법이 있습니다. 이러한 기술은 샘플에 존재하는 총 대장균 군과 박테리아를 정확하고 정량적으로 측정하는 데 도움이 됩니다.
설사나 용혈성 요독증후군(HUS)과 같은 물을 매개로 하는 질병의 유병률 증가와 청결한 음료수에 대한 세계의 요구 증가는 시장 전망을 밝게 하는 중요한 요인 중 하나 입니다. 대장균 검사는 질병과 질병의 확산을 방지하기 위해 지표수와 식수의 수질 모니터링에 도움이 됩니다. 또한 균의 유무(P/A) 검사로서 효소 기질 검사가 널리 채용되고 있는 것도 시장의 성장을 뒷받침하고 있습니다. 이러한 검사는 수행하기 쉽고 고급 실험 장치를 필요로 하지 않으며 가수분해 가능한 형광 기질을 사용하여 박테리아가 생산하는 다양한 효소의 존재를 검출합니다. 또한 혁신적인 박테리아 진단 장비 및 수질 검사법 시장 개척 등 다양한 기술의 진보도 시장 성장에 기여하고 있습니다. 그 밖의 요인으로는 대중의 건강 의식의 높아짐, 미생물학 부문에 있어서의 광범위한 연구개발(R&D) 활동 등을 들 수 있고, 시장의 추가 견인역이 될 것으로 기대됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 대장균 검사 시장은 지금까지 어떻게 추이해, 향후 어떻게 추이해 갈 것인가?
- COVID-19는 세계의 대장균 검사 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은?
- 제품별 시장 분석은?
- 검사 유형별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 대장균 검사 시장의 구조와 주요 진출기업은?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 대장균 검사 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
제7장 시장 내역 : 검사 유형별
- 환경 검사
- 시장 동향
- 주요 유형
- 막 여과(MF)
- 다관 발효(MTF)
- 효소 기질법
- 시장 예측
- 임상 검사
- 시장 동향
- 주요 유형
- 중합효소 연쇄반응(PCR) 검사
- 효소 면역 측정법(EIA)
- 기타
- 시장 예측
제8장 시장 분석 : 최종사용자별
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 진입업자의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Accugen Laboratories Inc.
- Alere Inc.(Abbott Laboratories)
- BD(Becton Dickinson and Company)
- bioMerieux(INSTITUT MERIEUX)
- Bio-RAD Laboratories Inc.
- Enzo Life Sciences Inc.(Enzo Biochem Inc.)
- Idexx Laboratories Inc.
- Johnson & Johnson
- Meridian Bioscience Inc.
- Nanologix Inc.
- Pro-Lab Diagnostics
- Qiagen NV
- Thermo Fisher Scientific Inc.
BJH
The global E. coli testing market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs). Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.
The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria. Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global E. coli testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, test type and end user.
Breakup by Product:
Consumables
Instruments
Breakup by Test Type:
Environmental Test
Membrane Filtration (MF)
Multiple Tube Fermentation (MTF)
Enzyme Substrate Methods
Clinical Test
Polymerase Chain Reaction (PCR) Tests
Enzyme Immunoassays (EIA)
Others
Breakup by End User:
Hospitals and Clinics
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMerieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global E. coli testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global E. coli testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global E. coli testing market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global E. Coli Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Test Type
- 7.1 Environmental Test
- 7.1.1 Market Trends
- 7.1.2 Major Types
- 7.1.2.1 Membrane Filtration (MF)
- 7.1.2.2 Multiple Tube Fermentation (MTF)
- 7.1.2.3 Enzyme Substrate Methods
- 7.1.3 Market Forecast
- 7.2 Clinical Test
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Polymerase Chain Reaction (PCR) Tests
- 7.2.2.2 Enzyme Immunoassays (EIA)
- 7.2.2.3 Others
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Laboratories
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Accugen Laboratories Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Alere Inc. (Abbott Laboratories)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 BD (Becton Dickinson and Company)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 bioMerieux (INSTITUT MERIEUX)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Bio-RAD Laboratories Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Enzo Life Sciences Inc. (Enzo Biochem Inc.)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Idexx Laboratories Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Johnson & Johnson
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Meridian Bioscience Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Nanologix Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Pro-Lab Diagnostics
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Qiagen N.V.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Thermo Fisher Scientific Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
